Clinical utility of PET-FDG imaging in differentiation of benign from malignant adrenal masses in lung cancer

Clinical Lung Cancer

Volumn 3, Issue 1, 2001, Pages 59-64

  Gupta, N C ^a   Graeber, G M ^a   Tamim, W J ^a   Rogers, J S ^a   Irisari, L ^a   Bishop, H A ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Adrenal enlargement; Adrenal metastasis; Benign; Computed tomography; Malignant; Sensitivity; Specificity

Indexed keywords

FLUORODEOXYGLUCOSE;

ADRENAL METASTASIS; ADRENAL TUMOR; ADULT; AGED; ARTICLE; BENIGN TUMOR; BIOPSY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EVALUATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; LUNG CANCER; MALE; MALIGNANT NEOPLASTIC DISEASE; POSITRON EMISSION TOMOGRAPHY; PREDICTION; SENSITIVITY AND SPECIFICITY;

EID: 0034794056     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2001.n.019     Document Type: Article

References (18)

1. Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer
2. Sensitivity and specificity of computed tomography for the detection of adrenal metastatic lesions among 91 autopsied lung cancer patients
3. Isolated adrenal masses in nonsmall-cell bronchogenic carcinoma
4. Sonographic guidance for the localization of peripheral pulmonary nodules during thoracoscopy
5. Upper abdominal computerized tomography scanning in staging non-small cell lung carcinoma
6. Non-small cell lung carcinoma adrenal metastases. Computed tomography and percutaneous needle biopsy in their diagnosis
7. The relationship of clinical findings to CT scan evidence of adrenal gland metastases in the staging of bronchogenic carcinoma
8. Patterns of adrenal gland involvement from lung cancer shown by 18F-fluorodeoxyglucose positron emission tomography compared to computed tomography and magnetic resonance imaging
9. Is computed tomography guided biopsy still necessary for the diagnosis of adrenal masses in patients with resectable non-small-cell lung cancer?
10. Adrenal masses: Characterization with delayed contrast-enhanced CT
11. Delayed enhanced CT for differentiation of benign from malignant adrenal masses
12. Benign adrenocortical masses: Diagnosis with chemical shift MR imaging
13. Adrenal masses in patients with malignancy: Prospective comparison of echo-planar, fast spin-echo, and chemical shift MR imaging
14. Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer. Impact of magnetic resonance imaging
15. Management of incidentally discovered adrenal masses and risk of malignancy
16. Survival determinants in extensive-stage non-small-cell lung cancer: The Southwest Oncology Group experience
17. Surgical management of adrenal metastases from lung cancer
18. Does resection of adrenal metastases from non-small cell lung cancer improve survival?